​

Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary

Aurinia Pharmaceuticals is owned by 59.14% institutional investors, 7.28% insiders, and 33.58% retail investors. Tang capital management is the largest institutional shareholder, holding 9.85% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.27% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals59.14%7.28%33.58%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management13.04M9.85%$221.36M
Blackrock9.27M6.44%$52.94M
Blackrock funding, inc. /de8.19M6.19%$139.04M
Goldman sachs group5.62M4.25%$95.36M
Nea management company3.97M3.00%$67.37M
Two sigma investments, lp3.47M2.62%$58.84M
Arrowstreet capital, limited partnership3.26M2.47%$55.39M
State street2.59M1.96%$43.95M
Morgan stanley2.31M1.74%$39.17M
Marshall wace, llp2.04M1.54%$34.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management13.04M10.05%$221.36M
Nea management company3.97M4.24%$67.37M
Hussman strategic advisors210.00K0.82%$3.56M
Ironwood investment management113.39K0.67%$1.92M
Precision wealth strategies71.01K0.36%$1.21M
Navellier & associates257.14K0.35%$4.36M
Rice hall james & associates416.63K0.34%$7.07M
Uniplan investment counsel189.54K0.30%$3.22M
Virtus investment advisers73.51K0.29%$1.25M
Pdt partners265.49K0.24%$4.51M

Top Buyers

HolderShares% AssetsChange
Goldman sachs group5.62M0.01%4.19M
Tang capital management13.04M10.05%814.61K
Blackrock9.27M0.00%609.18K
Sixth street partners management company445.99K0.00%445.99K
Blackrock funding, inc. /de8.19M0.00%347.56K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.63M
Rock springs capital management lp---1.18M
Man group83.89K0.00%-867.52K
Point72 asset management---849.62K
Readystate asset management lp---657.84K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company445.99K0.00%445.99K$7.57M
Hood river capital management269.31K0.04%269.31K$2.98M
Exoduspoint capital management, lp221.62K0.02%221.62K$3.76M
Caption management216.36K0.02%216.36K$3.67M
Norges bank114.05K0.00%114.05K$651.20K

Sold Out

HolderChange
Twin peaks wealth advisors-2.00
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00
Federation des caisses desjardins du quebec-40.00
Stephens consulting-45.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262905.45%78,287,9805.93%591.96%1558.39%7911.27%
Mar 31, 2026136-50.00%11,979,121-83.37%80.32%68-49.25%32-61.90%
Dec 31, 2025193-23.41%37,728,298-42.57%271.23%98-9.26%56-38.46%
Sep 30, 2025206-10.04%43,375,015-25.50%311.78%86-14.00%7720.31%
Jun 30, 20252271.79%58,203,989-6.12%412.10%99-1.98%646.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Russell 2000 ETF3.01M2.27%-53.47K
Fidelity Small Cap Index1.18M0.92%5.89K
iShares Russell 2000 Growth ETF1.08M0.82%-9.93K
iShares Biotechnology ETF832.39K0.63%-2.54K
Russell 2000 Equity Index Fund B773.72K0.60%17.68K
Russell 2000 Index Non-Lendable Fund773.72K0.60%17.68K
State St Russell Sm/Mid Cp® Indx NL Cl C820.80K0.60%-
State St Russell Sm/Mid Cp® Indx SL Cl I722.20K0.54%-
Vanguard Russell 2000 ETF686.51K0.53%73.25K
GS Glb Sm Cp CORE Eq Base Inc USD Snap598.50K0.47%503.00K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 01, 2026TANG KEVIN Chief Executive OfficerBuy$5.25M
May 29, 2026TANG KEVIN Chief Executive OfficerBuy$4.02M
Jun 02, 2026TANG KEVIN Chief Executive OfficerBuy$3.15M
Jun 01, 2026TANG KEVIN Chief Executive OfficerBuy$1.52K
May 29, 2026TANG KEVIN Chief Executive OfficerBuy$35.29K

Insider Transactions Trends

DateBuySell
2026 Q25-
2026 Q16-
2025 Q4--
2025 Q331
2025 Q2--

AUPH Ownership FAQ

Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 59.14%, followed by 7.28% insiders and 33.58% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 49.09%, which Aurinia Pharmaceuticals exceeds.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Tang capital management (13.04M shares, 9.85%), Blackrock (9.27M shares, 6.44%), and Blackrock funding, inc. /de (8.19M shares, 6.19%). Together, they hold 22.48% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.05% of its assets in 13.04M Aurinia Pharmaceuticals shares, valued at 221.36M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.27% of its total shares outstanding invested in 3.01M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools